Cancer genetics and genomics is a rapidly evolving field that focuses on understanding the genetic mutations and alterations that contribute to the development and progression of cancer. By studying the genetic makeup of both normal and cancerous cells, researchers are uncovering the underlying mechanisms that drive tumor formation. This knowledge is crucial for identifying specific biomarkers for early diagnosis, predicting treatment responses, and developing personalized therapies. Advances in genomic technologies, such as next-generation sequencing, have made it possible to analyze cancer genomes in unprecedented detail, paving the way for targeted therapies that can more effectively treat various types of cancer.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India